UroGen Pharma Ltd. (URGN)

USD 10.79

(-4.77%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 178.31 Million 136.23 Million 119.74 Million 122 Million 202.38 Million 103.55 Million
Total Current Assets 169.18 Million 128.9 Million 114.39 Million 115.61 Million 148.63 Million 102.24 Million
Cash And Short Term Investments 137.78 Million 99.96 Million 89.81 Million 103.91 Million 147.07 Million 101.31 Million
Cash and Cash Equivalents 95.82 Million 55.4 Million 44.36 Million 103.91 Million 49.68 Million 101.31 Million
Short Term Investments 41.96 Million 44.55 Million 44.77 Million 49.15 Million 97.38 Million -
Net Receivables 15.44 Million 12.7 Million 11.71 Million 7.04 Million - -
Inventory 5.67 Million 4.32 Million 4.83 Million 1.96 Million - -
Other Current Assets 10.28 Million 11.1 Million 7.47 Million 3.36 Million 1.03 Million 672 Thousand
Total Non-Current Assets 9.12 Million 6.71 Million 5.35 Million 6.38 Million 53.75 Million 1.31 Million
Net PPE 2.36 Million 3.74 Million 3.14 Million 4.2 Million 4.71 Million 948 Thousand
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 4.72 Million 223 Thousand 675 Thousand 1.89 Million 48.55 Million 51 Thousand
Tax Assets - - - - - -
Other Non Current Assets 2.03 Million 2.74 Million 1.53 Million 289 Thousand 487 Thousand 317 Thousand
Other Assets - 620 Thousand - - - -
Total Liabilities 243.52 Million 224.98 Million 111.33 Million 25.65 Million 22.08 Million 13.46 Million
Total Current Liabilities 31.21 Million 23.91 Million 22.38 Million 21.43 Million 19.48 Million 13.46 Million
Account Payables 6.51 Million 5.52 Million 5.78 Million 3.27 Million 4.69 Million 8.54 Million
Tax Payables - - - - - -
Short Term Debt 819 Thousand 941 Thousand 3.33 Million 1.85 Million - -
Deferred Revenue 4.39 Million 618 Thousand 497 Thousand 382 Thousand - -
Other Current Liabilities 19.48 Million 16.83 Million 12.76 Million 15.92 Million 14.78 Million 4.92 Million
Total Non Current Liabilities 212.31 Million 201.06 Million 88.95 Million 4.21 Million 2.6 Million -
Long-Term Debt 98.55 Million 99.12 Million 398 Thousand 1.49 Million 2.6 Million -
Deferred Revenue Non Current - - -2.84 Million -2.71 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 113.76 Million 98.92 Million 88.55 Million 2.71 Million - -
Other Liabilities - - - - - -
Total Equity -65.21 Million -88.74 Million 8.41 Million 96.35 Million 180.3 Million 90.09 Million
Stock Holders Equity -65.21 Million -88.74 Million 8.41 Million 96.35 Million 180.3 Million 90.09 Million
Common Stock 89 Thousand 63 Thousand 61 Thousand 60 Thousand 57 Thousand 44 Thousand
Retained Earnings -679.34 Million -577.1 Million -467.32 Million -356.5 Million -228.01 Million -122.87 Million
Accumulated other comprehensive income 12 Thousand -107 Thousand -25 Thousand 271 Thousand 276 Thousand -747 Thousand
Common Stock Equity -65.21 Million -88.74 Million 8.41 Million 96.35 Million 180.3 Million 90.09 Million
Capital Lease Obligation 844 Thousand 1.58 Million 398 Thousand 1.49 Million 2.6 Million -
Total Investments 46.69 Million 44.55 Million 45.45 Million 51.04 Million 145.94 Million 51 Thousand
Total Debt 100.21 Million 99.12 Million 398 Thousand 1.49 Million 2.6 Million -
Net Debt 4.39 Million 43.71 Million -43.96 Million -102.41 Million -47.08 Million -101.31 Million

Balance Sheet Charts